Wire by Fusion42
Fusion42 Scout Raise
The Debrief & Outliers
Regulatory RadarWorkday Debrief · Mon 09:00 UTCSector Deep DiveWorkday Debrief · Tue 09:00 UTCGeo PulseWorkday Debrief · Wed 09:00 UTCOperating ConditionsWorkday Debrief · Thu 09:00 UTCWeekly BriefingWorkday Debrief · Fri 09:00 UTCWTF Happened This WeekSat 09:00 UTC · 3σ outliers
Benchmarks
Benchmarks HomeBy News TypeBy RegionBy Sector
AI WeeklyAbout

Switch product

Fusion42RaiseScoutWire

The Debrief & Outliers

All editionsRegulatory RadarWorkday Debrief · Mon 09:00 UTCSector Deep DiveWorkday Debrief · Tue 09:00 UTCGeo PulseWorkday Debrief · Wed 09:00 UTCOperating ConditionsWorkday Debrief · Thu 09:00 UTCWeekly BriefingWorkday Debrief · Fri 09:00 UTCWTF Happened This WeekSat 09:00 UTC · 3σ outliers

Database & benchmarks

Benchmarks HomeBy News TypeBy RegionBy SectorStories

Account

Sign in
← Back

Wire · operational-macro

Q&A: USP CEO Urges Manufacturers to Act Now to Stop Drug Shortages

1 October 2026 · By · Wire by Fusion42

Published

1 October 2026

Topic

operational-macro

◆ Sectors

Health

◆ Geography

United States

◆ Source

Read at pharmtech.com →

◆ Verified

Fusion42 · 2 October 2026 · Fusion42 review

USP is launching a Drug Supply Chain Resilience Benchmark Initiative to incentivize manufacturers and purchasers toward resilient drug supply chains through procurement benchmarks, supply transparency, and regulatory capacity building, aiming to prevent drug shortages and strengthen onshoring and friendshoring options globally.

This Wire brief sits within Fusion42's coverage of Health.

◆ ◆ The Wire takeaway

You need to act now on supply resilience to avoid being squeezed out by new benchmarks favouring reliable suppliers. USP’s tools connect purchasing power to quality and supply stability, so start aligning your production and transparency efforts today.

◆ Coverage

1 source · 1 Oct 2026

◆ Related on Wire

◆ Topics

Healthdrug-shortagessupply-chainprocurementbenchmarksregulatory-standardsresilience